An inducible transposon mutagenesis approach for the intracellular human pathogen <i>Chlamydia trachomatis</i>.

O'Neill, Colette E; Skilton, Rachel J; Forster, Jade; Cleary, David W; Pearson, Sarah A; Lampe, David J; Thomson, Nicholas R; Clarke, Ian N

An inducible transposon mutagenesis approach for the intracellular human pathogen Chlamydia trachomatis.

O'Neill, Colette E; Skilton, Rachel J; Forster, Jade; Cleary, David W; Pearson, Sarah A; Lampe, David J; Thomson, Nicholas R; Clarke, Ian N.

Afiliación

O'Neill CE; Clinical and Experimental Sciences, University of Southampton, Southampton, Hampshire, SO166YD, UK.
Skilton RJ; Clinical and Experimental Sciences, University of Southampton, Southampton, Hampshire, SO166YD, UK.
Forster J; Cancer Sciences, University of Southampton, Southampton, SO16 6YD, UK.
Cleary DW; Clinical and Experimental Sciences, University of Southampton, Southampton, Hampshire, SO166YD, UK.
Pearson SA; Clinical and Experimental Sciences, University of Southampton, Southampton, Hampshire, SO166YD, UK.
Lampe DJ; Department of Biological Sciences, Duquesne University, Pittsburgh, Pennsylvania, 15116, USA.
Thomson NR; Bacterial Genomics and Evolution, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
Clarke IN; Clinical and Experimental Sciences, University of Southampton, Southampton, Hampshire, SO166YD, UK.

Wellcome Open Res ; 6: 312, 2021.

Article en En | MEDLINE | ID: mdl-35087955

Palabras clave

Chlamydia trachomatis; MinION; TraDIS; anhydrotetracycline; dual-control regulon; genetics; inducible promoter; riboswitch; theophylline; transposon mutagenesis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Wellcome Open Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido